Abstract
The use of topically applied epinephrine in the therapy of primary one-angle glaucoma is well-established. Recent studies suggest that the intraocular pressure response to topical epinephrine in patients with ocular hypertension may also have predictive value in deter mining which of such patients will develop glaucoma. The present paper reviews some of these studies, emphasizes certain of their limitations, and outlines plans to verify the conclusions suggested by the data.
Keywords
Intraocular Pressure Visual Field Defect Ocular Hypertension Visual Field Loss Glaucoma Group
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
Reference
- (1).Armaly, M.F.: Ocular pressure and visual fields: A ten year follow-up study. Arch. Ophthalmol. 81, 25 (1969)PubMedGoogle Scholar
- (2).Becker, B.; Morton, W.R.: Topical epinephrine in glaucoma suspects. Am. J. Ophthalmol. 62, 272 (1966)PubMedGoogle Scholar
- (3).Becker, B.; Shin, D.H.: Response to topical epinephrine: A practical prognostic test in patients with ocular hypertension. Arch. Ophthalmol. 94, 2057 (1976)PubMedGoogle Scholar
- (4).Becker, B.; Montgomery, S.W.; Kass, M.A.: Increased ocular and systemic responsiveness to epinephrine in primary open-angle glaucoma. Arch. Ophthalmol. 95, 789 (1977)PubMedGoogle Scholar
- (5).Bigger, J.F.; Palmberg, P.F.; Becker, B.: Increased cellular sensitivity to glucocorticoids in primary open-angle glaucoma. Invest. Ophthalmol, 11, 832 (1972)PubMedGoogle Scholar
- (6).Kass, M.A.; Becker, B.: A simplified test of epinephrine responsiveness. Arch. Ophthalmol. (in press) (1978)Google Scholar
- (7).Kitazawa, Y.: Problems on primary open-angle glaucoma. Acta Soc. Ophthalmol. Jpn. 79, 1715 (1975)Google Scholar
- (8).Linner, E.: Diagnostic and therapeutic aspects of early chronic simple glaucoma. Isr. J. Med. Sci. 8, 1394 (1972)PubMedGoogle Scholar
- (9).Linner, E.; Stromberg, U.: Ocular hypertension. In: Glaucoma Symposium, Tutzing Castle. Leydhecker, W. (ed.), p. 187. Basel: Karger 1967Google Scholar
- (10).Neufeld, A.H.; Jampol, L.M.; Sears, M.L.: Cyclic AMP in the aqueous humor: The effects of adrenergic action. Exp. Eye Res. 14, 242 (1973)CrossRefGoogle Scholar
- (11).Newell, P.C.: Inhibition of human leukocyte mitosis by prednisolone in vitro. Cancer Res. 21, 1518 (1961)Google Scholar
- (12).Norskov, K.: Routine tonometry in ophthalmic practice: II. Five year follow-up. Acta Ophthalmol. 48, 873 (1970)Google Scholar
- (13).Palmberg, P.F.; Hajeck, S.; Cooper, D.; Becker, B.: Increased cellular responsiveness to epinephrine in primary open-angle glaucoma. Arch. Ophthalmol. 95, 855 (1977)PubMedGoogle Scholar
- (14).Perkins, E.S.: The Bedford Glaucoma Survey: 1. Long-term follow-up of borderline cases. Br. J. Ophthalmol. 57, 179 (1973)PubMedCrossRefGoogle Scholar
- (15).Shin, D.H.; Kolker, A.E.; Kass, M.A.; Kaback, M.B.; Becker, B.: Long-term epinephrine therapy of ocular hypertension. Arch. Ophthalmol. 94, 2059 (1976)PubMedGoogle Scholar
- (16).Smith, J.W.; Steiner, A.L.; Newberry, W.M., et al: Cyclic adenosine 3′ 5′ -monophosphate in human lymphocytes. Alteration after phytohemagglutinin stimulation. J. Clin. Invest. 50, 432 (1971)PubMedCrossRefGoogle Scholar
- (17).Sutherland, E.W.; Oye, I.; Butcher, R.W.: The action of epinephrine and the role of adenylcyclase system in hormone action. Recent Prog Horm. Res. 21, 623 (1965)PubMedGoogle Scholar
- (18).Wilensky, J.T.; Podos, S.M.; Becker, B.: Prognostic indicators in ocular hypertension. Arch. Ophthalmol. 91, 200 (1974)PubMedGoogle Scholar
Copyright information
© Springer-Verlag Berlin Heidelberg 1979